Progyny Inc
NASDAQ:PGNY

Watchlist Manager
Progyny Inc Logo
Progyny Inc
NASDAQ:PGNY
Watchlist
Price: 24.57 USD 2.29% Market Closed
Market Cap: 2.1B USD
Section:
 

Relative Value

The Relative Value of one PGNY stock under the Base Case scenario is hidden USD. Compared to the current market price of 24.57 USD, Progyny Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PGNY Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

1.7
P/S
P/S
Price to Sales
1.7
vs History
80
vs Industry
53
Median 3Y
2.3
Median 5Y
3.7
Industry
2.3
Forward
1.6
More Details
37.2
P/E
P/E
Price to Earnings
37.2
vs History
79
vs Industry
16
Median 3Y
42.3
Median 5Y
60.2
Industry
22.5
Forward
30.9
More Details
10.2
P/OCF
P/OCF
Price to OCF
10.2
vs History
80
vs Industry
35
Median 3Y
14.4
Median 5Y
26.9
Industry
14.5
More Details
10.9
P/FCFE
P/FCFE
Price to FCFE
10.9
vs History
79
vs Industry
32
Median 3Y
14.7
Median 5Y
27.8
Industry
21.5
More Details
3.8
P/B
P/B
Price to Book Value
3.8
vs History
87
vs Industry
18
Median 3Y
5.4
Median 5Y
7.7
Industry
2.2
More Details
1.4
EV/S
EV/S
Enterprise Value to Sales
1.4
vs History
84
vs Industry
58
Median 3Y
2
Median 5Y
3.5
Industry
2.6
Forward
1.3
More Details
6
EV/GP
EV/GP
Enterprise Value to Gross Profit
6
vs History
85
vs Industry
35
Median 3Y
9.2
Median 5Y
16.2
Industry
5.2
More Details
19.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19.5
vs History
88
vs Industry
14
Median 3Y
32.5
Median 5Y
74.2
Industry
11.9
Forward
7.7
More Details
20.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
20.5
vs History
88
vs Industry
18
Median 3Y
33.8
Median 5Y
77.3
Industry
16.9
Forward
8.9
More Details
8.4
EV/OCF
EV/OCF
Enterprise Value to OCF
8.4
vs History
84
vs Industry
38
Median 3Y
12.7
Median 5Y
25
Industry
14.7
More Details
9.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
9.1
vs History
80
vs Industry
35
Median 3Y
13
Median 5Y
25.9
Industry
18.7
More Details
5.4
EV/IC
EV/IC
Enterprise Value to IC
5.4
vs History
80
vs Industry
14
Median 3Y
8.1
Median 5Y
11.6
Industry
1.9
More Details

Multiples Across Competitors

PGNY Competitors Multiples
Progyny Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Progyny Inc
NASDAQ:PGNY
2.1B USD 1.7 37.2 19.5 20.5
US
UnitedHealth Group Inc
NYSE:UNH
294.4B USD 0.7 16.7 11.1 12.9
US
Anthem Inc
LSE:0HG8
85.2B USD 0.4 15.4 10.8 12.7
US
Elevance Health Inc
NYSE:ELV
73B USD 0.4 13.2 9.6 11.3
US
Humana Inc
NYSE:HUM
31B USD 0.2 24 8.9 11.2
US
Centene Corp
NYSE:CNC
18.6B USD 0.1 -3.5 7.1 15.2
US
Healthequity Inc
NASDAQ:HQY
7.9B USD 6.2 53.9 19.9 31.3
US
Molina Healthcare Inc
NYSE:MOH
7.8B USD 0.2 8.9 2.1 2.4
US
Magellan Health Inc
F:MAH1
2.2B EUR 0.5 8.5 12.9 38.4
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
7.2B BRL 0.4 -15 3.2 5.8
US
Clover Health Investments Corp
NASDAQ:CLOV
1.3B USD 0.7 -22.4 -19.6 -19.2
P/E Multiple
Earnings Growth PEG
US
Progyny Inc
NASDAQ:PGNY
Average P/E: 22.2
37.2
27%
1.4
US
UnitedHealth Group Inc
NYSE:UNH
16.7
10%
1.7
US
A
Anthem Inc
LSE:0HG8
15.4
6%
2.6
US
Elevance Health Inc
NYSE:ELV
13.2
6%
2.2
US
Humana Inc
NYSE:HUM
24
25%
1
US
Centene Corp
NYSE:CNC
Negative Multiple: -3.5
-15%
N/A
US
Healthequity Inc
NASDAQ:HQY
53.9
67%
0.8
US
Molina Healthcare Inc
NYSE:MOH
8.9
-10%
N/A
US
M
Magellan Health Inc
F:MAH1
8.5
N/A N/A
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Negative Multiple: -15 N/A N/A
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -22.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Progyny Inc
NASDAQ:PGNY
Average EV/EBITDA: 10.5
19.5
58%
0.3
US
UnitedHealth Group Inc
NYSE:UNH
11.1
-3%
N/A
US
A
Anthem Inc
LSE:0HG8
10.8
1%
10.8
US
Elevance Health Inc
NYSE:ELV
9.6
1%
9.6
US
Humana Inc
NYSE:HUM
8.9
4%
2.2
US
Centene Corp
NYSE:CNC
7.1
-18%
N/A
US
Healthequity Inc
NASDAQ:HQY
19.9
26%
0.8
US
Molina Healthcare Inc
NYSE:MOH
2.1
-10%
N/A
US
M
Magellan Health Inc
F:MAH1
12.9
N/A N/A
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
3.2
8%
0.4
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -19.6 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Progyny Inc
NASDAQ:PGNY
Average EV/EBIT: 16.2
20.5
51%
0.4
US
UnitedHealth Group Inc
NYSE:UNH
12.9
-5%
N/A
US
A
Anthem Inc
LSE:0HG8
12.7
2%
6.4
US
Elevance Health Inc
NYSE:ELV
11.3
2%
5.6
US
Humana Inc
NYSE:HUM
11.2
8%
1.4
US
Centene Corp
NYSE:CNC
15.2
-22%
N/A
US
Healthequity Inc
NASDAQ:HQY
31.3
37%
0.8
US
Molina Healthcare Inc
NYSE:MOH
2.4
-11%
N/A
US
M
Magellan Health Inc
F:MAH1
38.4
N/A N/A
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
5.8
24%
0.2
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -19.2 N/A N/A

See Also

Summary
PGNY intrinsic value, competitors valuation, and company profile.
DCF Valuation
PGNY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PGNY stock valuation using valuation multiples.
Wall Street Estimates
PGNY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PGNY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 301,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.